These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 27633824)
1. Beta2-glycoprotein I Expression in Lupus Nephritis Patients with Antiphospholipid-associated Nephropathy. Gao R; Yu W; Wen Y; Li H J Rheumatol; 2016 Nov; 43(11):2026-2032. PubMed ID: 27633824 [TBL] [Abstract][Full Text] [Related]
2. Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis. Sciascia S; Radin M; Cecchi I; Fenoglio R; De Marchi A; Besso L; Baldovino S; Rossi D; Miraglia P; Rubini E; Roccatello D J Nephrol; 2020 Aug; 33(4):757-762. PubMed ID: 31974856 [TBL] [Abstract][Full Text] [Related]
3. Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndrome. Kolyada A; Ke Q; Karageorgos I; Mahlawat P; Barrios DA; Kang PM; Beglova N J Thromb Haemost; 2016 Jun; 14(6):1298-307. PubMed ID: 26990752 [TBL] [Abstract][Full Text] [Related]
5. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up. Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I Arthritis Res Ther; 2015 Apr; 17(1):109. PubMed ID: 25927214 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies. Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173 [TBL] [Abstract][Full Text] [Related]
8. Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases. Shen Y; Chen XW; Sun CY; Dai M; Yan YC; Yang CD Lupus; 2010 Sep; 19(10):1195-203. PubMed ID: 20504833 [TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies in patients with lupus nephritis: clinical correlations and associations with long-term outcomes. Yap DYH; Thong KM; Yung S; Tang C; Ma BMY; Chan TM Lupus; 2019 Oct; 28(12):1460-1467. PubMed ID: 31594451 [TBL] [Abstract][Full Text] [Related]
10. Association of antiphospholipid antibodies with clinical activity and renal pathological activity in patients with lupus nephritis. Zhang J; Zhang J; Zhou Q; Lu G; You X Lupus; 2021 Jun; 30(7):1140-1145. PubMed ID: 33832360 [TBL] [Abstract][Full Text] [Related]
11. Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus. Silvariño R; Sant F; Espinosa G; Pons-Estel G; Solé M; Cervera R; Arrizabalaga P Lupus; 2011 Jun; 20(7):721-9. PubMed ID: 21486929 [TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases. Zheng H; Chen Y; Ao W; Shen Y; Chen XW; Dai M; Wang XD; Yan YC; Yang CD Arthritis Res Ther; 2009; 11(3):R93. PubMed ID: 19545416 [TBL] [Abstract][Full Text] [Related]
13. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response. Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371 [TBL] [Abstract][Full Text] [Related]
14. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome. Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022 [TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid syndrome: 30 years and our contribution. Koike T Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556 [TBL] [Abstract][Full Text] [Related]
16. Anti-β2GPI antibodies stimulate endothelial cell microparticle release via a nonmuscle myosin II motor protein-dependent pathway. Betapudi V; Lominadze G; Hsi L; Willard B; Wu M; McCrae KR Blood; 2013 Nov; 122(23):3808-17. PubMed ID: 23954892 [TBL] [Abstract][Full Text] [Related]
17. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome. von Scheven E; Glidden DV; Elder ME Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489 [TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies in patients with lupus nephritis. Fialová L; Zima T; Tesar V; Mikulíková L; Malbohan IM; Merta M; Certíková V Ren Fail; 2003 Sep; 25(5):747-58. PubMed ID: 14575283 [TBL] [Abstract][Full Text] [Related]
19. TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome. Xie H; Kong X; Zhou H; Xie Y; Sheng L; Wang T; Xia L; Yan J Clin Immunol; 2015 Oct; 160(2):198-210. PubMed ID: 26065621 [TBL] [Abstract][Full Text] [Related]
20. The role of antiphospholipid antibodies in lupus nephropathy. Perdiguero M; Boronat M; Marco P; Rivera F Nephron; 1995; 71(1):35-9. PubMed ID: 8538846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]